How many stocks are there of Medcom Tech?
The current number of stocks of Medcom Tech is 12.92 M undefined.
Medcom Tech Stocks 2024
Medcom Tech Stocks
12.92 M
Ticker
MED.MC
ISIN
ES0161857018
In 2024, Medcom Tech had 12.92 M outstanding stocks, a -0.03% change from the 12.92 M stocks in the previous year.
The Medcom Tech Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2022 | 12.92 |
| 2021 | 12.92 |
| 2020 | 12.94 |
| 2019 | 12.98 |
| 2018 | 13.21 |
| 2017 | 11.53 |
| 2016 | 10.24 |
| 2015 | 10.31 |
| 2014 | 10.31 |
| 2013 | 10.1 |
| 2012 | 10.1 |
| 2011 | 9 |
| 2010 | 9.01 |
| 2009 | 6.42 |
| 2008 | 6.42 |
| 2007 | 6.42 |
| 2006 | 6.42 |
Medcom Tech shares outstanding ES0161857018 ·
3 years
5 years
10 years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Medcom Tech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Medcom Tech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Medcom Tech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medcom Tech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2006 | 6.42 M Aktien |
| 2007 | 6.42 M Aktien |
| 2008 | 6.42 M Aktien |
| 2009 | 6.42 M Aktien |
| 2010 | 9.01 M Aktien |
| 2011 | 9 M Aktien |
| 2012 | 10.1 M Aktien |
| 2013 | 10.1 M Aktien |
| 2014 | 10.31 M Aktien |
| 2015 | 10.31 M Aktien |
| 2016 | 10.24 M Aktien |
| 2017 | 11.53 M Aktien |
| 2018 | 13.21 M Aktien |
| 2019 | 12.98 M Aktien |
| 2020 | 12.94 M Aktien |
| 2021 | 12.92 M Aktien |
| 2022 | 12.92 M Aktien |
Medcom Tech Aktienanalyse
What does Medcom Tech do?
Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Medcom Tech's Shares Outstanding
Medcom Tech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Medcom Tech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Medcom Tech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Medcom Tech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Medcom Tech Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Medcom Tech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Medcom Tech evolved in recent years?
The number of shares of Medcom Tech has increased by -0.03% gesunken compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Medcom Tech as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Medcom Tech?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Medcom Tech pay?
Over the past 12 months, Medcom Tech paid a dividend of 0.03 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, Medcom Tech is expected to pay a dividend of 0 EUR.
What is the dividend yield of Medcom Tech?
The current dividend yield of Medcom Tech is 3.4 %.
When does Medcom Tech pay dividends?
Medcom Tech pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Medcom Tech?
Medcom Tech paid dividends every year for the past 0 years.
What is the dividend of Medcom Tech?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Medcom Tech located?
Medcom Tech is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medcom Tech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medcom Tech from 1/5/2016 amounting to 0.03 EUR, you needed to have the stock in your portfolio before the ex-date on 1/5/2016.
When did Medcom Tech pay the last dividend?
The last dividend was paid out on 1/5/2016.
What was the dividend of Medcom Tech in the year 2023?
In the year 2023, Medcom Tech distributed 0 EUR as dividends.
In which currency does Medcom Tech pay out the dividend?
The dividends of Medcom Tech are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Medcom Tech
Our stock analysis for Medcom Tech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medcom Tech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.